Prectival

Main information

  • Trade name:
  • Eliminall 402 mg spot-on solution for dogs
  • Pharmaceutical form:
  • Spot-on solution
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Eliminall 402 mg spot-on solution for dogs
    Ireland
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • fipronil
  • Therapeutic area:
  • Dogs

Other information

Status

  • Source:
  • HMA - Europe
  • Authorization number:
  • UK/V/0381/005
  • Authorization date:
  • 28-09-2011
  • EU code:
  • UK/V/0381/005
  • Last update:
  • 09-08-2016

Summary of Product characteristics: dosage,interactions,side effects

Issued:November2011

AN:00587/2010

Page1of7

SUMMARYOFPRODUCTCHARACTERISTICS

1. NAMEOFTHEVETERINARYMEDICINALPRODUCT

Eliminall402mgspot-onsolutionfordogs

Exprolinevet402mgspot-onsolutionfordogs

Eliminall402mgspot-onsolutionfordogs(Austria,France,Germany,Greece,Italy,

Ireland,Luxemburg,Netherlands,UnitedKingdom,Portugal,Spain)

Exprolinevet402mgspot-onsolutionfordogs(Norway,Denmark,Finland,Sweden)

2. QUALITATIVEANDQUANTITATIVECOMPOSITION

1pipette(4.02ml)contains:

Activesubstance:

Fipronil 402mg

Excipients:

Butylhydroxyanisole(E320) 0.80mg

Butylhydroxytoluene(E321) 0.40mg

Forafulllistofexcipients,seesection6.1.

3. PHARMACEUTICALFORM

Spot-onsolution.

Lightyellowtoyellow,clearliquid.

4. CLINICALPARTICULARS

4.1 Targetspecies

Dogs

4.2 Indicationsforuse,specifyingthetargetspecies

Treatmentofflea(Ctenocephalidesspp.)andtick(Dermacentorreticulatus)

infestations.

FortreatmentofTrichodectescanisbitingliceinfestationsondogs.Mostliceare

killedwithin2days.

Insecticidalefficacyagainstnewinfestationswithadultfleaspersistsforupto8

weeks.

Issued:November2011

AN:00587/2010

Page2of7

Theproducthasapersistentacaricidalefficacyforupto3weeksagainstIxodes

ricinusandupto4weeksagainstRhipicephalussanguineusandDermacentor

reticulatus.Ifticksofsomespecies(Ixodesricinus,Rhipicephalussanguineus)are

presentwhentheproductisapplied,alltheticksmaynotbekilledwithinthefirst48

hours.

TheproductcanbeusedaspartofatreatmentstrategyforthecontrolofFleaAllergy

Dermatitis(FAD)wherethishasbeenpreviouslydiagnosedbyaveterinarysurgeon.

4.3 Contraindications

Donotuseonpuppieslessthan2monthsoldand/orweighinglessthan2kginthe

absenceofavailabledata.

Donotuseonsick (e.g.systemicdiseases,fever…)orconvalescentanimals.

Donotuseinrabbits,asadversereactionsandevendeathcouldoccur.

Thisproductisspecificallydevelopedfordogs.Donotuseincats,asthiscouldlead

tooverdosing.

Donotuseincasesofhypersensitivitytotheactivesubstance,dimethylsulphoxide

ortoanyofotherexcipients.

4.4 Specialwarningsforeachtargetspecies

Bathing/immersioninwaterwithintwodaysafterapplicationoftheproductshouldbe

avoided.Afterweeklyimmersionsinwaterforoneminutetheperiodofpersistent

insecticidalefficacyagainstfleaswas7weeks.

Theproductdoesnotpreventticksfromattachingtotheanimals.Iftheanimalhas

beentreatedpriortoexposuretotheticks,thetickswillbekilledinthefirst24-48

hoursafterattachment.Thiswillusuallybepriortoengorgement,minimisingbutnot

excludingtheriskoftransmissionofdiseases.Oncedead,tickswilloftendropoffthe

animal,butanyremainingticksmayberemovedwithagentlepull.

Fleasfrompetsofteninfesttheanimal'sbasket,beddingandregularrestingareas

suchascarpetsandsoftfurnishingswhichshouldbetreated,incaseofmassive

infestationandatthebeginningofthecontrolmeasures,withasuitableinsecticide

andvacuumedregularly.

WhenusedaspartofastrategyforthetreatmentoffleaAllergyDermatitis,monthly

applicationstotheallergicpatientandtootherdogsinthehouseholdare

recommended.

Foroptimalcontroloffleainfestationinmulti-pethousehold,alldogsandcatsinthe

householdshouldbetreatedwithasuitableinsecticide.

Issued:November2011

AN:00587/2010

Page3of7

4.5 Specialprecautionsforuse

i)Specialprecautionsforuseinanimals

Animalsshouldbeweighedaccuratelypriortotreatment.

Avoidcontactwiththeanimal'seyes.Inthecaseofaccidentaleyecontact,

immediatelyandthoroughlyflushtheeyeswithwater.

Itisimportanttomakesurethattheproductisappliedtoanareawheretheanimal

cannotlickitoffandtomakesurethatanimalsdonotlickeachotherfollowing

treatment.

Donotapplytheproductonwoundsordamagedskin.

ii)Specialprecautionstobetakenbythepersonadministeringtheveterinary

medicinalproducttoanimals

Thisproductcancausemucousmembraneandeyeirritation.Therefore,contact

betweentheproductandthemouthoreyesshouldbeavoided.

Inthecaseofaccidentaleyecontactimmediatelyandthoroughlyflushtheeyeswith

water.Ifeyeirritationpersistsseekmedicaladviceandshowthepackageleafletor

thelabeltothephysician.

Donotsmoke,drinkoreatduringapplication.

Avoidcontentscomingintocontactwiththefingers.Ifthisoccurs,washoff

immediatelywithsoapandwater.

Washhandsafteruse.

Peoplewithaknownhypersensitivitytofipronilordimethylsulphoxideorother

excipientsshouldavoidcontactwiththeveterinarymedicinalproduct.

Treatedanimalsshouldnotbehandleduntiltheapplicationsiteisdry,andchildren

shouldnotbeallowedtoplaywithtreatedanimalsuntiltheapplicationsiteisdry.Itis

thereforerecommendedthatanimalsarenottreatedduringtheday,butshouldbe

treatedduringtheearlyevening,andthatrecentlytreatedanimalsshouldnotbe

allowedtosleepwithowners,especiallychildren.

iii)Otherprecautions

Fipronilmayadverselyaffectaquaticorganisms.Dogsshouldnotbeallowedtoswim

inwatercoursesfor2daysafterapplication.

4.6Adversereactions(frequencyandseriousness)

Iflickingoccurs,abriefperiodofhypersalivationmaybeobserved.

Amongtheextremelyraresuspectedadversereactions,transientcutaneous

reactionsontheapplicationsite(skindiscoloration,localalopecia,pruritus,

erythema)andgeneralpruritusoralopeciahavebeenreportedafteruse.

Exceptionally,hypersalivation,reversibleneurologicsymptoms(hyperesthesia,

depression,nervoussymptoms),vomitingorrespiratorysymptomshavebeen

observedafteruse.

Issued:November2011

AN:00587/2010

Page4of7

4.7 Useduringpregnancy,lactationorlay

Laboratorystudiesusingfipronilhavenotshownanyevidenceofteratogenicor

embryotoxiceffect.Studieshavenotbeencarriedoutwiththisproductinpregnant

andlactatingbitches.Useinpregnancyandlactationonlyinaccordancewith

professionalveterinaryadviceandabenefit/riskassessment.

4.8Interactionwithothermedicinalproductsandotherformsofinteraction

Noneknown.

4.9 Amountstobeadministeredandadministrationroute

Routeofadministrationanddosage:

Externaluseonly.

Administerbytopicalapplicationtotheskinaccordingtothebodyweightasfollows:

1pipetteof4.02mlperdogweighingover40kgupto60kgbodyweight,andone

pipetteof4.02mlandanappropriatesmallerpipetteperdogweighingover60kg

bodyweight.

Methodofadministration:

Removethepipettefromthetriplexbag.Holdthepipetteinanuprightposition,twist

andpullthecapoff.Turnthecaparoundandplacetheotherendofthecapbackon

thepipette.Pushandtwistthecaptobreaktheseal,thenremovethecapfromthe

pipette.Spreadtheanimalhairsintheareabetweentheshoulderbladestomakethe

skinvisible.Putthetipofthepipetteontotheskinandpresstheunit-dosepipette

severaltimestoemptyitscontentsdirectlyontotheskinatoneortwospots.

Itisimportanttomakesurethattheproductisappliedtoanareawheretheanimal

cannotlickitoff,andtomakesurethatanimalsdonotlickeachotherfollowing

treatment.

Thehairshouldbepartedandtheproductappliedtotheskin.Temporarychangesto

thecoat(clumped/greasyhairand/ordepositsonthehair)maybenotedatthe

applicationsite.

Treatmentschedule:

Foroptimalcontroloffleaand/ortickinfestationthetreatmentschedulecanbebased

onthelocalepidemiologicalsituation.

Intheabsenceofsafetystudies,theminimumtreatmentintervalis4weeks.

Issued:November2011

AN:00587/2010

Page5of7

4.10Overdose(symptoms,emergencyprocedures,antidotes),ifnecessary

Noadverseeffectswereobservedintargetanimalsafetystudiesin8week-old

puppies,growingdogsanddogsweighingabout2kgtreatedonceatfivetimesthe

recommendeddose.Theriskofexperiencingadverseeffects(seesection4.6)may

howeverincreasewhenoverdosing,soanimalsshouldalwaysbetreatedwiththe

correctpipettesizeaccordingtobodyweight.

4.11Withdrawalperiod

Notapplicable.

5. PHARMACOLOGICALPROPERTIES

Pharmacotherapeuticgroup:Ectoparasiticidesfortopicaluse.

ATCvetcode:QP53AX15

5.1 Pharmacodynamicproperties

Fipronilisaninsecticideandacaricidebelongingtothephenylpyrazolefamily.Itacts

byinhibitingtheGABAcomplex,bindingtothechloridechannelandtherebyblocking

pre-andpost-synaptictransferofchlorideionsacrosscellmembranes.Thisresultsin

uncontrolledactivityofthecentralnervoussystemanddeathofinsectsoracarids.

Fipronilexhibitsaninsecticidalandacaricidalactivityagainstfleas(Ctenocephalides

spp),ticks(Rhipicephalusspp,Dermacentorspp,IxodessppincludingIxodes

ricinus,andlice(Trichodectescanis)inthedog.Tickswillusuallybekilledwithin48h

aftercontactwithFipronil,howeverifticksofsomespecies(Ixodesricinus,

Rhipicephalussanguineus)arealreadypresentwhentheproductisapplied,allofthe

ticksmaynotbekilledwithinthefirst48hours.Fleaswillbekilledwithin24hours.

5.2 Pharmacokineticproperties

Fipronilismainlymetabolisedtoitssulfonederivative(RM1602),whichalso

possessesinsecticidalandacaricidalproperties.Theconcentrationsoffipronilonthe

hairdecreasewithtime.

6. PHARMACEUTICALPARTICULARS

6.1Listofexcipients

Butylhydroxyanisole(E320)

Butylhydroxytoluene(E321)

Polysorbate80

PovidoneK25

Dimethylsulfoxide

Issued:November2011

AN:00587/2010

Page6of7

6.2Incompatibilities

Noneknown.

6.3Shelflife

Shelf-lifeoftheveterinarymedicinalproductaspackagedforsale:36months.

6.4.Specialprecautionsforstorage

Storeintheoriginalcontainerinordertoprotectfromlightandmoisture.

6.5Natureandcompositionofimmediatepackaging

Whitepolypropylenepipetteclosedwitheitherapolyethyleneorpolyoxymethylene

cap.Eachpipetteispackedinapolyethyleneterephthalate/aluminium/lowdensity

polyethylenetriplexbag.

Boxcontaining1,3,6,10,20or30pipettes.

Notallpacksizesmaybemarketed.

6.6 Specialprecautionsforthedisposalofunusedveterinarymedicinal

productorwastematerialsderivedfromtheuseofsuchproducts

Anyunusedveterinarymedicinalproductorwastematerialsderivedfromsuch

veterinarymedicinalproductsshouldbedisposedofinaccordancewithlocal

requirements.

Fipronilmayadverselyaffectaquaticorganisms.Donotcontaminateponds,waterways

orditcheswiththeproductoremptycontainer.

Issued:November2011

AN:00587/2010

Page7of7

7. MARKETINGAUTHORISATIONHOLDER

KRKA,d.d.,Novomesto

Šmarješkacesta6

8501Novomesto

Slovenia

8. MARKETINGAUTHORISATIONNUMBER

Vm01656/4033

9. DATEOFFIRSTAUTHORISATION

15November2011

10. DATEOFREVISIONOFTHETEXT

November2011

25-6-2018

Ministers: voedselveiligheid verder versterken urgent

Ministers: voedselveiligheid verder versterken urgent

De Commissie Sorgdrager heeft een grondige analyse gemaakt van de wijze waarop de fipronilcrisis is afgehandeld en spreekt alle relevante actoren –het bedrijfsleven, de toezichthouders en departementen– aan op hun functioneren. Het beeld dat het rapport schetst is niet fraai. De pluimveehouders die nog steeds met de gevolgen van de crisis kampen, voelen het als geen ander.  De aanbevelingen om de voedselveiligheid verder te versterken worden opgevolgd. Dat schrijven de ministers Bruno Bruins en Carola Sc...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

25-6-2018

Commissie onderzoek fipronil in eieren: geef voedselveiligheid topprioriteit

Commissie onderzoek fipronil in eieren: geef voedselveiligheid topprioriteit

Bedrijven in de eierketen, de NVWA en de ministeries van VWS en LNV hebben onvoldoende voorrang gegeven aan voedselveiligheid. Bedrijven in de eierketen maken hun wettelijke verantwoordelijkheid niet waar. Bij de NVWA krijgt voedselveiligheid te weinig aandacht. Politiek en bestuur hebben een te beperkte opvatting over hun eigen rol ten aanzien van voedselveiligheid en komen pas in actie als zich een incident of crisis voordoet. Dat zijn de belangrijkste conclusies uit het rapport van de Commissie onderz...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

29-6-2018

BROADLINE (Merial)

BROADLINE (Merial)

BROADLINE (Active substance: Fipronil/ S-methoprene/ Eprinomectin/ Praziquantel) - Centralised - Yearly update - Commission Decision (2018) 4164 of Fri, 29 Jun 2018

Europe -DG Health and Food Safety

30-4-2018

CERTIFECT (Merial)

CERTIFECT (Merial)

CERTIFECT (Active substance: (S)-Methoprene, Fipronil, Amitraz) - Withdrawal - Commission Decision (2018)2687 of Mon, 30 Apr 2018

Europe -DG Health and Food Safety